CCL2 and breast cancer: Interestingly, it has been shown that in vitro exposure of human monocytes to CCL2 results in the enrichment of the CD14+CD16+ cell subset and that this chemokine is responsible for inflammatory monocyte accumulation induced by breast cancer cell microenvironment (30).